FIELD: biotechnology.
SUBSTANCE: invention relates to biotechnology, in particular to a method of screening derived from mesenchymal stem cells promoting regeneration of neuronal cells (versions). Present invention also relates to a neuronal regeneration-promoting cell induced from a palatine tonsil-derived mesenchymal stem cell, as well as to a pharmaceutical composition containing it, and its use for treating a neurological disease. Said neuronal cell has the following characteristics: a) expression of markers CD121a, CD106 and CD112 is increased in comparison with palatine tonsil-derived mesenchymal stem cell; and b) expression of markers CD26 and CD141 is reduced in comparison with palatine tonsil-derived mesenchymal stem cell.
EFFECT: present invention provides a screening of regenerative neuronal cells exhibiting a neuronal regenerative effect from a number of different cells differentiated from mesenchymal stem cells, based on analysis of specific CD markers.
14 cl, 12 dwg, 2 tbl, 8 ex
             
         
            
              
                | Title | Year | Author | Number | 
							
              
                | USING MESENCHYMAL AND NEURONAL MARKER EXPRESSING STEM CELLS AND THEIR COMPOSITIONS FOR TREATING NEUROLOGICAL DISEASES (VERSIONS) | 2017 | 
										Kerkis, IrinaValverde Ventseslau, Kristian | RU2742828C2 | 
							
              
                | STEM CELLS EXPRESSING MESENCHYMAL AND NEURONAL MARKERS, COMPOSITIONS THEREOF AND METHODS OF PRODUCING SAID MESENCHYMAL AND NEURONAL MARKERS | 2017 | 
										Kerkis, IrinaValverde Ventseslau, Kristian | RU2741839C2 | 
							
              
                | 3D IN VITRO TWO-PHASE OSTEOCHONDRAL CONSTRUCT | 2013 | 
										Rozovski MarkFatekhi-Farkani SkhirinLauster RolandMarks Uve | RU2615439C2 | 
							
              
                | METHODS AND COMPOSITIONS FOR USE IN CELL THERAPY | 2010 | 
										Lombardo EleuterioBusher Dirk | RU2610427C2 | 
							
              
                | EXTRACELLULAR VESICLES ORIGINATING FROM MESENCHYMAL STEM CELLS | 2019 | 
										De Frantsisko, AnzhelitaKhan, Chzhunchao | RU2805066C2 | 
							
              
                | MESENCHYMAL STEM CELLS ORIGINATING FROM PERINATAL TISSUE: METHOD FOR THEIR PRODUCTION AND USE | 2017 | 
										Khan, ChzhunchaoKhan, ChzhiboVan, Tao | RU2780179C2 | 
							
              
                | METHODS OF PRODUCING INDUCED SMOOTH MUSCLE CELLS | 2020 | 
										Thurner MarcoMarksteiner Rainer | RU2815906C2 | 
							
              
                | MARROW STROMAL CELL MATERIAL FOR APPLICATION IN BLOOD VESSEL FORMATION AND GENERATION OF ANGIOGENETIC AND TROPHIC FACTORS | 2003 | 
										Chopp MajklLi I.Chehn' Sjaoguan | RU2332223C2 | 
							
              
                | METHOD OF PRODUCING MESENCHYMAL STEM CELLS FROM HUMAN PLURIPOTENT STEM CELLS AND MESENCHYMAL STEM CELLS OBTAINED ACCORDING TO THIS METHOD | 2020 | 
										Kim, Ki NamChoi, Sung HyunOh, BoramChoi, Mi KyungCho, Jun Kwon | RU2823729C1 | 
							
              
                | METHOD FOR PRODUCING INDUCED REPROGRAMMED DERIVATIVE NEURONAL STEM CELLS FROM NON-NEURONAL CELLS BY USING HMGA2 | 2014 | 
										Kang Kyung SunJu Kyung Rok | RU2646099C2 |